Delivery Order SPE2DB22D1017-SPE2DB25FG7BP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Qualipita 60 mg tablets in a quantity of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $2,528.32 under a firm fixed price arrangement with an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Qualipita 30 mg tablets in quantities of 30 units, with a ceiling value of $2,393.85. This is a firm fixed price delivery order with an ultimate completion date of July 15, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $7,240.64 to AmerisourceBergen Drug Corp for the supply of Qualipita 60 mg tablets (30-count units) on August 26, 2025, with completion expected by August 27, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's primary distribution hub...
- The Defense Logistics Agency awarded a $8,924.51 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Qualipita 60 mg tablets (30-count units) under a firm fixed-price contract structure. This competitively awarded, non-set-aside delivery order is set to conclude by July 29, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $7,277.80 to AmerisourceBergen Drug Corp for Qualipita 60 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to...
- The Defense Logistics Agency awarded a delivery order valued at $2,289.25 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Qualipita 60 mg tablets (30-count units). This firm fixed-price contract, with an ultimate completion date of August 26, 2025, represents a competitive, non-set-aside award for pharmaceutical delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $10,507.55 to AmerisourceBergen Drug Corp for Qualipita 60 mg tablets (30-count) on May 22, 2025, with completion scheduled for May 23, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a direct fulfillment of pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Qualipta™ 60 mg tablets (30-count) with a ceiling value of $3,947.30. This is a firm fixed-price delivery order with an ultimate completion date of June 4, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a $2,875.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Qualipita 60 mg tablets (30-count units) on May 23, 2025, with an ultimate completion date of May 27, 2025. This non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Qualipita 60 mg tablets (30-count units) with a ceiling value of $1,534.32. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG7BPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Qualipita 60 mg tablets (30-count) with a ceiling value of $6,073.01. This competitively awarded, firm fixed-price delivery order is not associated with any set-aside designation and requires completion by July 11, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability to compete successfully for federal medical procurement needs is evidenced by its extensive portfolio of delivery orders covering diverse therapeutic domains and price points, positioning it as a critical vendor within the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 7/10/25 |